Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs

The Food and Drug Administration (FDA) approved a new class of anti-diabetic medication (a sodium–glucose co-transporter 2 (SGLT2) inhibitor) in 2013. However, SGLT2 inhibitor drugs are under evaluation due to their associative side effects, such as urinary tract and genital infection, urinary disco...

詳細記述

書誌詳細

主要な著者:	Mutaib M. Mashraqi, Navaneet Chaturvedi, Qamre Alam, Saleh Alshamrani, Mosa M. Bahnass, Khurshid Ahmad, Amany I. Alqosaibi, Mashael M. Alnamshan, Syed Sayeed Ahmad, Mirza Masroor Ali Beg, Abha Mishra, Sibhghatulla Shaikh, Syed Mohd Danish Rizvi
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-01-01
シリーズ:	Molecules
主題:	sodium–glucose co-transporters 2 FimH uropathogenic bacteria urinary tract infections diabetes
オンライン･アクセス:	https://www.mdpi.com/1420-3049/26/3/582
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!